Shanghai - Delayed Quote CNY

Guangxi LiuYao Group Co., Ltd (603368.SS)

17.16
-0.12
(-0.69%)
At close: 3:00:03 PM GMT+8
Advanced Chart
Loading Chart for 603368.SS
  • Previous Close 17.28
  • Open 17.25
  • Bid 17.16 x --
  • Ask 17.17 x --
  • Day's Range 17.14 - 17.29
  • 52 Week Range 14.53 - 23.56
  • Volume 3,964,500
  • Avg. Volume 8,662,097
  • Market Cap (intraday) 6.845B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 8.25
  • EPS (TTM) 2.08
  • Earnings Date --
  • Forward Dividend & Yield 0.60 (3.47%)
  • Ex-Dividend Date Jun 11, 2024
  • 1y Target Est --

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.

web.lzyy.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Distribution

Industry

More about Guangxi LiuYao Group Co., Ltd

Recent News: 603368.SS

View More
View More

Performance Overview: 603368.SS

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

603368.SS
3.92%
SSE Composite Index (000001.SS)
0.87%

1-Year Return

603368.SS
24.33%
SSE Composite Index (000001.SS)
8.36%

3-Year Return

603368.SS
18.39%
SSE Composite Index (000001.SS)
9.61%

5-Year Return

603368.SS
13.95%
SSE Composite Index (000001.SS)
17.86%

Compare To: 603368.SS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

603368.SS
Guangxi LiuYao Group Co., Ltd
17.16
-0.69%
Mkt Cap CNY 6.845B
Industry Medical Distribution
YI
111, Inc.
7.61
-2.44%
Mkt Cap 65.959M
Industry Medical Distribution

Statistics: 603368.SS

View More

Valuation Measures

As of 5/14/2025

  • Market Cap

    6.89B

  • Enterprise Value

    8.81B

  • Trailing P/E

    8.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    9.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.04%

  • Return on Assets (ttm)

    3.83%

  • Return on Equity (ttm)

    11.57%

  • Revenue (ttm)

    21.18B

  • Net Income Avi to Common (ttm)

    854.87M

  • Diluted EPS (ttm)

    2.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.61B

  • Total Debt/Equity (mrq)

    55.17%

  • Levered Free Cash Flow (ttm)

    246.46M

View More

Research Analysis: 603368.SS

View More
View More

People Also Watch

601607.SS Shanghai Pharmaceuticals Holding Co., Ltd
18.26
-0.54%
 
600998.SS Jointown Pharmaceutical Group Co., Ltd
5.19
-0.95%
 
600056.SS CHINA MEHECO
10.31
-0.19%
 
603883.SS LBX Pharmacy Chain Joint Stock Company
18.80
-3.34%
 
603858.SS Shandong Buchang Pharmaceuticals Co., Ltd.
15.89
+0.38%
 
601717.SS Zhengzhou Coal Mining Machinery Group Company Limited
15.39
-1.22%
 
603609.SS Wellhope Foods Co., Ltd.
8.71
+1.28%
 
600970.SS Sinoma International Engineering Co.,Ltd
9.39
-1.05%
 
601117.SS China National Chemical Engineering Co., Ltd
8.02
-1.11%
 
603686.SS FULONGMA GROUP Co.,Ltd.
13.20
-0.75%
 
600566.SS Hubei Jumpcan Pharmaceutical Co., Ltd.
26.75
+0.11%
 
603328.SS Guangdong Ellington Electronics Technology Co.,Ltd
8.96
-1.54%
 
601098.SS China South Publishing & Media Group Co., Ltd
14.19
+1.43%
 
600750.SS Jiang Zhong Pharmaceutical Co.,Ltd
23.12
+0.17%
 
600993.SS Mayinglong Pharmaceutical Group Co., Ltd.
27.80
+3.23%
 
601233.SS Tongkun Group Co., Ltd.
11.24
-0.97%